<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01738048</url>
  </required_header>
  <id_info>
    <org_study_id>H-D-2007-0099B</org_study_id>
    <nct_id>NCT01738048</nct_id>
  </id_info>
  <brief_title>Persistent Pain After Reconstruction Following Mastectomy</brief_title>
  <official_title>Persistent Pain After Reconstruction Following Mastectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rigshospitalet, Denmark</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Danish Breast Cancer Cooperative Group</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Rigshospitalet, Denmark</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A cross sectional study to determine the prevalence of persistent pain after reconstructive
      surgery after mastectomy for breast cancer, with a comparative analysis of a cohort treated
      with mastectomy without reconstruction.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The aim of the study is to determine if reconstruction of the breast after mastectomy
      increases the risk of reporting persistent pain 2-3 years after surgery.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2008</start_date>
  <completion_date type="Actual">April 2008</completion_date>
  <primary_completion_date type="Actual">April 2008</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>The risk of developing persistent if reconstructed</measure>
    <time_frame>Cross-sectional, 2-3 years after surgery for breast cancer</time_frame>
    <description>The risk of developing persistent if reconstructed compared to patients mastectomized without reconstruction expressed as an odds ratio.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Prevalence of persistent pain after reconstruction after mastectomy</measure>
    <time_frame>Cross-sectional, 2-3 years after surgery for breast cancer</time_frame>
    <description>Self reported pain expressed as a percentage of the population of patients reconstructed with expander and autologous tissue. Pain intensity measured with a numerical rating scale 0-10, divided in mild (NRS 1-3), moderate (4-6) and severe pain (7-10). Patients regarded as having clinically relevant pain: NRS 4 or above, at least at a weekly basis.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Prevalence of sensory disturbances after reconstruction after mastectomy</measure>
    <time_frame>Cross-sectional, 2-3 years after surgery for breast cancer</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">1352</enrollment>
  <condition>Breast Cancer</condition>
  <condition>Chronic Pain</condition>
  <arm_group>
    <arm_group_label>Mastectomy</arm_group_label>
    <description>Patients treated with mastectomy without reconstruction</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Reconstruction</arm_group_label>
    <description>Patients treated with mastectomy followed by reconstruction</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Reconstruction</intervention_name>
    <description>Reconstructive surgery after mastectomy, either by expander or autologous tissue. Includes both primary and secondary reconstruction</description>
    <arm_group_label>Reconstruction</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Nationwide cross-sectional cohort
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with unilateral primary breast cancer aged 18-70 years

        Exclusion Criteria:

          -  recurrent cancer

          -  other malignancy

          -  emigration

          -  non-standardized treatment
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kenneth G Andersen, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rigshospitalet, University of Copenhagen</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Rigshospitalet</name>
      <address>
        <city>Copenhagen</city>
        <zip>2100</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <reference>
    <citation>Andersen KG, Kehlet H. Persistent pain after breast cancer treatment: a critical review of risk factors and strategies for prevention. J Pain. 2011 Jul;12(7):725-46. doi: 10.1016/j.jpain.2010.12.005. Epub 2011 Mar 24. Review.</citation>
    <PMID>21435953</PMID>
  </reference>
  <verification_date>November 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 22, 2012</study_first_submitted>
  <study_first_submitted_qc>November 29, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 30, 2012</study_first_posted>
  <last_update_submitted>November 29, 2012</last_update_submitted>
  <last_update_submitted_qc>November 29, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 30, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Rigshospitalet, Denmark</investigator_affiliation>
    <investigator_full_name>Kenneth Geving Andersen</investigator_full_name>
    <investigator_title>Physician, research fellow</investigator_title>
  </responsible_party>
  <keyword>Pain</keyword>
  <keyword>Neuropathic pain</keyword>
  <keyword>Chronic pain</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Chronic Pain</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

